CrushSCI.com
200.4Average days
184Median days
70Fastest days
386Longest days
1152025 publications

Paper Review Records

All Paper Review Records

16 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

129 days

TP53 shapes tumour-specific immune phenotypes across breast, colorectal and kidney human cancers

Authors
Rita Bonfiglio; Valeria Palumbo; Francesca Servadei; Erica Giacobbi; Lukas Funke; Jonathan Woodsmith; Pier Luigi Bove; Enrico Finazzi Agrò; Simone Albisinni; Oreste Claudio Buonomo; Giuseppe S. Sica; Eleonora Candi; Gerry Melino; Alessandro Mauriello; Manuel ScimecaShow moreShow less
Affiliations
1. Department of Experimental Medicine, TOR, University of Rome Tor Vergata, Rome, Italy; 2. Indivumed GmbH, Falkenried, Hamburg, Germany; 3. Department of Surgical Sciences, University of Rome Tor Vergata, Rome, Italy; 4. Urology Unit, Department of Surgical Sciences, Tor Vergata University Hospital, University of Rome Tor Vergata, Rome, Italy; 5. Division of Breast Unit, Department of Surgical Sciences, School of Medicine and Surgery, Tor Vergata University of Rome, Rome, ItalyShow moreShow less
Source PDF DOI Publisher page
184 days

Inhibition of ELK1 promotes osteogenic differentiation of periodontal ligament stem cells by reducing ubiquitin-mediated degradation of DLX2

Authors
Xiao Zeng; Yajing Shi; Changwei Cao; Qin Liu; Wenjia Tan; Chaoju Wen; Yuanyuan Jia; Helin Chen; Wenjie Li; Qiang DongShow moreShow less
Affiliations
1. Department of Prosthodontics, Guizhou Province, The Affiliated Stomatology Hospital of Guizhou Medical University, Guiyang, PR ChinaShow moreShow less
Source PDF DOI Publisher page
184 days

Release factor 3 degradation enhances aminoglycoside-mediated translational readthrough at MECP2 nonsense mutations

Authors
Dennis Lebeda; Daniela Smoljanow; Julia Hofhuis; Sven ThomsShow moreShow less
Affiliations
1. Department for Biochemistry and Molecular Medicine, Medical School OWL, Bielefeld University, Bielefeld, GermanyShow moreShow less
Source PDF DOI Publisher page
150 days

NUAK isoforms promote glucose and glutamine metabolic reprogramming driven colon cancer progression and migration through regulation of AMPK/mTOR signaling

Authors
Acily Skadon Worral Wilfred Raj; Jaithanya Yesupogu Moorthy Babu; Rajalakshmi Sabanayagam; Sridhar Muthusami; Ravi ManoharanShow moreShow less
Affiliations
1. Department of Biochemistry, Guindy Campus, University of Madras, Chennai, India; 2. Department of Biochemistry, Karpagam Academy of Higher Education, Coimbatore, India; 3. Centre for Cancer Research, Karpagam Academy of Higher Education, Coimbatore, IndiaShow moreShow less
Source PDF DOI Publisher page
205 days

The epigenetic-metabolic axis of trained immunity: dual roles in disease pathogenesis and intervention

Authors
Liqi Liao; Zhe Zhai; Linglin Zhong; Chenyu Shi; Shunyu Yao; Lingling Tao; Yong-Xian Cheng; Xuhan LiuShow moreShow less
Affiliations
1. School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou, China; 2. Guangdong Provincial Key Laboratory of Chinese Medicine Ingredients and Gut Microbiomics, Institute for Inheritance-Based Innovation of Chinese Medicine, Marshall Laboratory of Biomedical Engineering, School of Pharmacy, Shenzhen University Medical School, Shenzhen University, Shenzhen, China; 3. College of Basic Medicine, Yunnan University of Chinese Medicine, Yunnan, ChinaShow moreShow less
Source PDF DOI Publisher page
131 days

Copper-induced suppression of the PPARα–FABP1 axis sensitizes hepatocytes to ferroptosis in Wilson disease

Authors
Yingjie Li; Yaoyi Wu; Yanwen Zhou; Liyan Zhao; Zhenyu Xu; Yimin Zhang; Ning ZhouShow moreShow less
Affiliations
1. Department of Infectious Diseases, The Second Xiangya Hospital, Central South University, Changsha, China; 2. State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Hangzhou, ChinaShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does JOURNAL OF MOLECULAR MEDICINE-JMM take to review a manuscript?

As of 2026-11-19, CrushSCI has 16 complete review records for JOURNAL OF MOLECULAR MEDICINE-JMM. The fastest paper went from submission to acceptance in 70 days (Kinase regulation of miRNA networks in cardiometabolic disease: emerging pathways to precision therapy, received 2026-05-07, accepted 2026-07-16); the slowest took 386 days. The average is 200.4 days and the median is 184 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.